Showing results (131-140 of 376) with videos related to
Sort By:
Pageof 38
Journal of Cardiovascular Translational Research|January 18, 2014
Association of thrombin generation potential with platelet PAR-1 regulation and P-selectin expression in patients on dual antiplatelet therapyRoza Badr Eslam, Florian Posch, Irene M Lang, et al.Journal of Thrombosis and Haemostasis : JTH|May 16, 2025
Bleeding risk and performance of bleeding risk assessment models in patients with venous thromboembolism on anticoagulation: results from the prospective observational bleeding and assess long-term outcomes on health in patients with venous thromboembolism (BACH-VTE) studyTimothy Hoberstorfer, Stephan Nopp, Daniel Steiner, et al.Atherosclerosis|April 19, 2011
The P-selectin gene Pro715 allele and low levels of soluble P-selectin are associated with reduced P2Y12 adenosine diphosphate receptor reactivity in clopidogrel-treated patientsThomas Gremmel, Christoph W Kopp, Sabine Steiner, et al.Haematologica|May 26, 2018
Frequency, risk factors, and impact on mortality of arterial thromboembolism in patients with cancerElla Grilz, Oliver Königsbrügge, Florian Posch, et al.Eclinicalmedicine|September 2, 2025
Arterial and venous thromboembolic events in patients with cancer treated with targeted therapies: a population-based cohort studyFlorian Moik, Erzsébet Horváth-Puhó, Cihan Ay, et al.Thrombosis and Haemostasis|October 9, 2018
Association of Platelet-to-Lymphocyte Ratio and Neutrophil-to-Lymphocyte Ratio with the Risk of Thromboembolism and Mortality in Patients with CancerElla Grilz, Florian Posch, Oliver Königsbrügge, et al.Thrombosis Research|April 30, 2013
Response to antiplatelet therapy is independent of endogenous thrombin generation potentialThomas Gremmel, Simon Panzer, Sabine Steiner, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2015
Soluble Vascular Endothelial Growth Factor (sVEGF) and the Risk of Venous Thromboembolism in Patients with Cancer: Results from the Vienna Cancer and Thrombosis Study (CATS)Florian Posch, Johannes Thaler, Gerhard-Johann Zlabinger, et al.Thrombosis Journal|December 1, 2022
Atrial fibrillation and anticoagulation are associated with hospitalisations in patients with end-stage kidney disease on haemodialysis: a prospective population-based cohort studyDaniel Steiner, Sabine Schmaldienst, Matthias Lorenz, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 6, 2022
Growth differentiation factor-15 predicts major bleeding, major adverse cardiac events and mortality in patients with end-stage kidney disease on haemodialysis: findings from the VIVALDI studyStephan Nopp, Oliver Königsbrügge, Sabine Schmaldienst, et al.Pageof 38